Compare Heron Therapeutics Inc (HRTX) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Standard Lithium Ltd — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Standard Lithium Ltd is far larger — about 9.8× Heron Therapeutics Inc's market cap, and Standard Lithium Ltd is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | SLI | |
|---|---|---|
Market Cap | $61.47M | $604.50M |
Sector | Health | Basic Materials |
52-Week High | $1.49 | $5.65 |
52-Week Low | $0.32 | $1.93 |
Enterprise Value | $168.21M | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
